发明公开
- 专利标题: CITRULLINE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE
- 专利标题(中): 瓜氨酸作为风险指标心血管疾病
-
申请号: EP10754233.4申请日: 2010-03-22
-
公开(公告)号: EP2409157A2公开(公告)日: 2012-01-25
- 发明人: HANZEN, Stanley, L. , WANG, Zeneng
- 申请人: The Cleveland Clinic Foundation
- 申请人地址: 9500 Euclid Avenue Cleveland, OH 44195 US
- 专利权人: The Cleveland Clinic Foundation
- 当前专利权人: The Cleveland Clinic Foundation
- 当前专利权人地址: 9500 Euclid Avenue Cleveland, OH 44195 US
- 代理机构: Carlisle, Julie
- 优先权: US181855P 20090528; US161841P 20090320
- 国际公布: WO2010108180 20100923
- 主分类号: G01N33/68
- IPC分类号: G01N33/68 ; G01N33/53
摘要:
Diagnostic tests and methods for characterizing an individual's risk of having or developing cardiovascular disease (CVD), monitoring an individual's response to intervention aimed at preventing or reducing CVD, assessing an individual's risk of experiencing an adverse cardiovascular event, and/or determining whether a subject requires intervention as a result of being at risk of having CVD are described. The methods are useful for identifying those individuals who are in need of intervention aimed at reducing the risk or severity of CVD as well as those individuals who do not require aggressive intervention targeted at preventing CVD.
公开/授权文献
- EP2409157B1 CITRULLINE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE 公开/授权日:2015-11-04
信息查询
IPC分类: